Video summary
Fraud and abuse within the healthcare sector represent a massive financial drain, estimated to cost between 3% and 10% of annual spending, yet whistleblowing remains the most effective method for uncovering these issues, accounting for 40% of all detected cases. Whistleblowing is defined as raising concerns based on a sincere belief that wrongdoing harms the public interest, encompassing a wide range of issues from corruption and safety hazards to bullying and inadequate care. While financial incentives like those under the False Claims Act can yield significant returns for fraud detection, they do not always address critical concerns regarding patient safety or scientific integrity where monetary recovery is not the primary objective. Consequently, effective systems must go beyond simple financial rewards to foster a culture where individuals feel safe speaking up without fear of retribution.
Despite its importance, whistleblowers face severe risks, with over half encountering retaliation ranging from demotion and harassment to career stalling and, in extreme cases, death. Legal protections vary significantly across the globe; while some nations have implemented financial rewards and confidentiality measures, only about half of UN member states possess full laws guaranteeing freedom from retaliation. In the United States, protection comes from a complex patchwork of legislation including the False Claims Act, Occupational Safety Laws, HIPAA, and the Whistleblower Protection Act, though proving malice or navigating these statutes can be challenging for federal employees. Low volumes of reports often reflect a culture of silence driven by fear rather than an absence of problems, highlighting the urgent need for robust organizational leadership that actively encourages reporting through multiple channels, such as independent watchdogs and internal compliance officers, rather than ignoring issues to protect reputation.
The path toward systemic change requires moving beyond individual case resolutions to achieve "double-loop learning," which involves understanding the root causes of misconduct to prevent recurrence. Successful initiatives, such as those by the Global Fund, demonstrate that transparency in publishing corruption reports and implementing consequences for fraud can drive meaningful reform. Advocacy groups continue to maintain bipartisan support for whistleblower laws despite political polarization, emphasizing that continued education and respect are essential to sustaining whistleblowing as a vital tool against fraud. However, there are growing concerns about the politicization of whistleblowing, particularly in contested areas like diversity initiatives or gender-affirming care, where it risks being weaponized against marginalized groups rather than serving as a mechanism for justice.
Ultimately, protecting whistleblowers demands a combination of strong legal frameworks, tailored social support systems, and research that accounts for diverse cultural contexts. The goal is to create environments where reporting mechanisms function effectively and where individuals are honored for their courage in exposing wrongdoing. By translating individual cases into broader policy changes through impact litigation and advocacy, organizations can foster a culture of integrity that prioritizes public interest over institutional silence. As the webinar concludes, the emphasis remains on building resilient systems globally that not only detect fraud but also ensure the safety and well-being of those who stand up for ethical standards in healthcare and beyond.
Read the full video transcript
Good morning, good afternoon, good
evening everyone depending on where you
are. Thank you for joining us today. Uh
my name is Crystal Chang and um I am
here with the center for bioeththics. Um
joined by our uh presenters and
moderator for our protecting
whistleblowers and fighting fraud women
seminar session. At this time I will
hand this over to Leah um to um take us
through. If you have any questions
throughout the session, please feel free
to use the Q&A um and we will try our
best to get through them. Thank you.
>> Thank you Crystal and welcome. Thank you
for joining us this afternoon um for a
topic that I'm very excited to learn
about. Um so the health policy and
bioeththics seminar is a webinar that we
convene throughout the year with the aim
of learning about current issues in
health policy and thinking through some
of their ethical implications with the
aim of fostering conversation among
different disciplines and perspectives
on that topic. So we hope that today
gets you thinking and sends everyone out
with some new questions and ideas to
pursue. Um during the Q uh during the
webinar, please ask lots of questions.
We have time for a Q&A and please use
the Q&A function on Zoom that's on the
lower part of the screen in the panel
control. We'll be drawing questions from
the Q&A feature. So to start us off
today, I want to introduce our panelists
beginning with our moderator Alexander
Egleman who is a senior research
assistant with the program on regulation
therapeutics and law. His current
research focuses on anti-competitive
practices that undermine patient access
to affordable, safe, and innovative
treatments. And his work has appeared in
JAMAMA, Annals of Internal Medicine, the
BMJ, and the New York Times. He's also a
graduate of Habford College. So'll be
guiding us through the discussion today.
Presenting will be Taran Van who is
professor in the school of nursing and
health professions at the University of
San Francisco. Dr. Van is a public
health scholar and academic leader whose
work has furthered efforts to control
corruption in the health sector, advance
health systems and access to medicines
and evaluate public private partnerships
and community health initiatives. Dr.
Van has published over 140 articles,
book chapters and professional reports
and has served on international
technical committees and advised the
World Health Organization, Council of
Europe, World Bank, Bill and Melinda
Gates Foundation and other clients. She
is a returned Peace Corps volunteer from
Cameroon and has a PhD in public policy
and global health from Boston University
and a master's in health policy
management from the Harvard School of
Public Health. Joining her is Maya
Ephrad who serves as government
accountability projects director of
legislative and congressional affairs.
In her role, Miss Friday leads the
organization's federal legislative
advocacy work, and works directly with
national coalition partners, legislative
staff on the Hill, including member
committee and leadership offices and
others to defend and advance
whistleblower rights. She was previously
public policy council at the Brennan
Center for Justice, where her work
focused on voting rights, criminal
justice reform, elections, and good
governance reforms. She also previously
served in various legislative and
research capacities with the campaign
for tobaccof free kids, national
whistleblower center, represent us, fair
vote center for American progress and
the Michigan Innocence Clinic. She holds
a JD from the University of Michigan Law
School and a masters in public policy
from the University of Michigan, Gerald
R. Ford School of Public Policy. So,
thank you for joining us today and what
I'm sure will be a great conversation.
And over to you, Alex.
>> Thanks, Leah. and thank you all for
joining today. Concerns about fraud and
misconduct in healthcare aren't new and
today they operate at a massive scale
with estimates suggesting that three to
10% of healthcare spending may be lost
to fraud amounting at tens or even
hundreds of billions of dollars each
year. Of course, these uh issues affect
much more than budgets. They can
undermine patient care, compromise
scientific integrity, and erode public
trust. Whistleblowers are often the
mechanism by which these problems come
to come to light. But relying on
individuals to speak up raises broader
questions. How about how systems are
designed to promote accountability about
what motivates people to come forward
and how effective the laws and policies
both incentivize whistleblowing and
protect such individuals from
retaliation. Today's discussion will
move from a broader global perspective
on whistleblowing and anti-corruption to
a more detailed look at you the US legal
framework framework and real world
cases. We'll also have about 15 minutes
for questions at the end. So, please
submit them as we go and I'll do my best
to bring them into the conversation.
With that, I'll turn it over to Taran uh
to get us started.
>> Thank you so much. Let me share my
screen.
Uh so Maya and I have decided I'll give
an introduction to some of the
principles and uh definitions involved
and I'll also present some of my
findings from research that I did with a
team on whistleblowing in the global
context whistleblowing in health
organizations.
So, whistleblowing is the act of raising
concerns about suspicions uh or observed
suspected or observed wrongdoing. So, it
doesn't have to be that you have all the
facts in the row, but you have a a good
suspicion that wrongdoing um is being um
perpetrated and you're raising that to
pos people in position to do something
about it. So a whistleblower is someone
who exposes information or activity
deemed to be illegal, unethical or
incorrect in an within an organization.
So who cares? Why do we want people to
blow the whistle? Well, um as Alexander
has mentioned, fraud and abuse are
estimated to cost 58 to 84 billion in
the US alone per year. World Health
Organization estimates 500 billion per
year is lost worldwide from corruption
in the health sector. Whistleblowing um
reporting by employees is the single
most important way that we detect
occupational fraud accounting for 40% of
fraud cases detected. Occupational fraud
being deliberate misuse or
misappropriation of employee employer
resources and assets for personal
enrichment. And um the whistleblowing
also helps to detect inadequate patient
care which we're very concerned about.
And finally, whistleblowing enables an
organization to make systemic changes to
their systems to prevent wrongdoing in
the future.
So a few things on the nuts and bolts of
whistleblowing. A whistleblowing policy
within an organization will determine uh
who can be a whistleblower. Definitely
employees and former employees are
targeted. But uh sometimes and
especially in health, it's important to
open up whistleblowing to people like
volunteers, interns, um patients and
their families and also vendors or um
suppliers working with the health
organization.
What types of things might someone want
to report? As mentioned, it could be uh
something that threatens the public
interest. For example, an incompetent or
an impaired um person working in the
health care system, inadequate quality
of care, a workplace bully, bullying and
harassment, corruption, which um broadly
is defined as the abuse of entrusted
power for private gain and fraud. uh
defined as intentional deception,
concealment or misrepresentation of
material facts to secure unfair or
illegal unlawful gain. Um when as I
mentioned you don't have to be entirely
certain about the facts but should
sincerely think that the continuation of
this activity will uh harm the public
interest. Sincere belief, not trying to
get back at someone. So, um, if it turns
out when it's investigated that it was
not abuse, you won't be, uh, blamed for
having reported it. But these are things
that are spelled out usually in a
whistleblowing policy. Often people try
first to raise an issue internally with
their supervisor, with the compliance
office. Uh, sometimes that can work.
Sometimes there's it's difficult because
you're not sure who's involved or um or
nothing may happen. And in that case,
someone may decide to blow the whistle
externally with a funding organization,
with a regulator or other ways. Um,
people may report before or after
leaving an organization.
And then how do you report? Each
organization will have a policy about
the uh whistleblowing channel or
channels plural. There might be a an
Mass, for example, Mass General Bighgam
has a compliance hot helpline, a phone
number that you can report ethical or
legal violations through. Boston
University uses a third-party
managed whistleblowing system called
Ethics Point. I don't know, maybe there
are other hospitals or organizations
that use the same company. Uh,
confidentiality is very important.
Whistleblowing platforms generally allow
confidential reporting or promise
confidential reporting, meaning you
identify yourself as a as someone who's
making the report, but that identifying
information about the reporter is kept
confidential.
Anonymity, if if you're allowed to do
anonymous reporting, your name is not
given. And we'll come back to that
later. The pros and cons of confidential
versus anonymous whistleblowing.
So the work that I did with the team, I
do a lot of work. Uh I'm retired now
from University of San Francisco, but I
have my own company and through that I
do consulting on transparency,
accountability and anti-corruption,
anti-fraud measures in health systems
globally. And in 2022, I led a team that
conducted this um scoping review of
whistleblowing in health organizations
focused on low and middle inome
countries. And the idea was to better
understand how those systems work to um
prevent or reduce fraud and corruption.
So the first thing we looked at was the
types and the frequency of corruption
reported through whistleblowing systems.
And what we found that is in a lot of
countries, people use that um
whistleblowing portal for things other
than fraud or corruption. They may uh
report, of course, we want to hear about
any kinds of issues of harming patient
care, but they also report being unhappy
because they didn't get a promotion or
other personal grievances that might
normally go to an HR office if it was um
functional
reports we found were increasing at
multi-ateral organizations over time uh
due to two reasons. First World Health
Organization reported a lot more people
um using whistleblowing mechanism during
COVID but also because of outreach and
information given like the global fund
was trying to promote use of
whistleblowing systems in the different
countries where they were giving grants.
uh the example of the um
global
alliance, the Gavi Alliance, um they did
report that they their reporting had
substantially increased. First they had
like three reports per year from 2013 to
2020 and then in 2020 or 2021 they got
uh 67 reports. Now, when the the reports
come in, an office has the
responsibility to investigate them. 16
were found to have merit. The ones that
weren't found to have merit were ones
they said were either misdirected, like
those HR complaints that should have
gone to someone else or reflected
antivaxer sentiment or just were
nonsubstant substantive. Um the ones
that were found to have merit were
mainly related to vaccine equity that uh
the gave fund was not following their
own policies and procedures regarding
who had access who were the priorities
for receiving the vaccines when they
came out. And over time as uh more
supply was available these complaints
decreased and they had made some changes
to the system.
This is a second slide I wanted to show
about World Health Organization
receiving complaints through their
hotline. They received in uh 11 months
in 2020, it's almost a year of data. Uh
they received 276 reports from staff and
from the general public and they were
18% were analyzed to be and found to be
violations of codes of ethics or
professional conduct and conflicts of
interest that were undeclared.
About 9% were HR issues, breaches of
staff roles and rules and regulations.
Um 8% were suspected fraud, corruption
or bribery. 4% were abuse of authority
and that included harassment
and about uh 58% so the majority were
concerned sounding the alarm about the
danger to public health and personal
safety uh due to co 19 pandemic. So a
lot about lack of access to PPE.
Unfortunately, we don't know whether
these investigations were completed and
what were the outcomes of the
investigations. This is a gap in
understanding how um whistleblowing
policies are are implemented
factors. Another thing we looked at was
the factors that influence
whistleblowing and we found really four
main factors. One is the possibility of
financial reward and Maya will talk a
little more about that. We learned that
financial incentives are operating or
have operated in the US, India, China,
and the Republic of Korea. Earlier um
last this month, I learned about a
whistleblowing system that has financial
rewards being set up in Usbekiststan.
Appeal to duty is more prevalent in
multilateral organizations that that
don't offer uh financial rewards but uh
appeal to people's responsibility as a
um employee to it's their duty to report
and same with nursing profession. Um a
lot of emphasis on professional values
that um make it a responsibility to
report wrongdoing. multiple channels for
whistleblowing very important in low and
middle inome countries people had set up
systems that were based on web
providing a report through a website or
through a telephone but in Albania they
found people really wanted to come in
and talk personally they didn't they
didn't use those other mechanisms they
wanted that personal touch uh so looking
at that is important and finally uh
confidentiality ity and whistleblowing
protection is really critical. Um, some
people might be too afraid to report
even with confidentiality just because
they don't believe that confidentiality
can really be um promised. But and PE
some whistleblowing mechanisms are only
confidential reporting. They don't allow
anonymous because they want to be able
to prosecute based on the report. But
there are values to having anonymous
whistleblowing even in instead of
confidential. Um someone not giving
their name at all can still if there are
enough complaints and they have enough
details you could target some internal
control activities or even an audit uh
based on an anonymous complaint. or um
people might be able to make system
improvements to reduce the possibility
of corruption based on anonymous
information. So there is value to having
anonymous reports even though you can't
prosecute based on them.
Retaliation critical problem with
whistleblowing. Um more than half of
whistleblowers said they faced
retaliation.
The UN defines retaliation as any direct
or indirect detrimental action that aver
adversely affects the employment or
working conditions of an individual such
as um where those kinds of actions were
threatened or taken for the purposes of
punishing, intimidating or injuring an
individual as a result of them that
individual reporting misconduct. And our
study found many as you can see many
types of retaliation
uh demotion pressure to quit uh loss of
job changed responsibilities stalled
career progression and at the extreme
being referred as to psychiatric
treatment. You must be crazy if you
think this is happening. Um referred to
as a traitor or even personal harm and
death. two um medical chiefs in Utar
Pradesh stayed in India in 2012 were
murdered as they raised concerns about
alleged corruption in a rural health
program. So this is very critical and
it's why we try to have legal um
protections for whistleblowers. very
important health policy topic and legal
issue and the laws have to provide
strong protection of confidentiality and
repercussions for having um retaliated.
So if there's documented retaliation,
there should be some kind of punishment.
also should be a system in place to to
in um investigate claims that you've
been retal that a whistleblower has been
retaliated against. Um there could also
be support fi financial but also
psychological to whistleblowers. This is
a very difficult thing to do to blow the
whistle and they need some support.
There are international treaties um
again for that that have agreed to have
protection against um protection of
confidentiality and protection against
retaliation. But an analysis of UN
member states showed that just under
half had put in place um laws that
ensure freedom from retaliation and that
have full protection of confidentiality.
So there's a ways to go.
Country context can be important to
consider. Uh working globally on
policies and laws. There isn't one
sizefits-all.
Endemic how endemic corruption is, how
prevalent corruption is in the health
sector is an important factor. Um
prevalence of violence as a retaliation
danger should be considered. and the
value that in a country is placed on
personal relationships and reciprocity
and how things get done. This especially
in China and I saw it in my work in the
Philippines that um people there's a
negative perception of whistleblowers as
um not being loyal to the community if
they're stepping out. So these we need
to have tailored interventions to change
social norms a bit around whistleblowing
in some countries. The final thing that
we looked at in our research was the
impacts of whistleblowing. Could we
document um things there in terms of the
consequences? We showed a lot of we saw
a lot of evidence of um retaliation but
not a lot of evidence of the positive
effects of whistleblowing and that may
be because we um excluded news reports.
We were mainly looking for more
thoroughly studied um articles,
reflective articles, academic articles
maybe because it's not appearing in that
literature but we need to try and
document the positive effects that
whistleblowing where it can be um can
happen and we have some of that that
Maya will talk about in the US
and to conclude whistleblowing systems
design and functioning really depends
depends on a lot of factors, personal,
organizational and contextual factors,
and that includes leadership. There's
not a lot of implementation research on
whistleblowing, and I think we should
support such research to determine the
best ways to promote whistleblowing
while also protecting whistleblowers
from retaliation.
And finally, legal and social supports
are really needed for whistleblowers.
This can be a very difficult thing to
do, but it's a common good for society.
And we should think about how to share
the cost of protecting whistleblowers
who choose to call out wrongdoing in the
interests of protecting the public.
I have uh some teaching cases on
whistleblowing and we can share at least
this slide uh after the workshop so that
people or I can put the link into the
chat so that people if you're teaching
whistleblowing these are some cases I've
developed that I'm happy to share and
also selective references if people want
to read more. So thank you Alexander
back to you.
>> Great. Thank you so much. Mai, do you
want to go next?
>> All right. I hope that's now visible to
everybody. Um, I'm going to build on
what Taran has just presented and so
you'll see some things overlap and some
things build off of it in a way that I
hope sparks ideas and conversation and
we're more than happy to answer
questions at the end as well.
Um, I will talk about some notable and
some less well-known healthcare
whistleblower cases. The goal there is
to see how individuals can stand up, how
um whistleblowing shows moral courage.
It's a way of speaking truth to power.
And I'm also going to talk about some
key laws that protect whistleblowers in
the US as a way of understanding what
kind of protections do whistleblowers
have in various scenarios. And if we do
have time at the end, I have one current
example of a legal challenge um that I
think is really interesting and very on
point.
Um, Taran's already talked about who is
a whistleblower. And so what I want to
do is focus on uh what is a
whistleblower in the eyes of US law. Um,
there's no single law that protects
whistleblowers in the US. It's a
patchwork of laws, but uh the primary
ones define a whistleblower uh with a
few key pieces that Taran has already
mentioned, but I think is important for
someone to think about. Um, two key
points. The first being that
whistleblowers typically tend to be
current and former employees and they
have direct credible evidence. They tend
to become aware of it while they're on
the job. As Turn mentioned, that might
not be literally their job. Maybe it's a
volunteer in this current context. Um,
but that is the way that most
whistleblowers tend to first come across
their information. Um, the second that's
quite important with US law is that the
concerns are serious. um the disclosure
tends to promote legal compliance or
protects the public interest. If it
doesn't do so, that disclosure of a
whistleblower does not actually rise to
the standard of quote unquote
whistleblowing that's protected under
the WPA and most other US whistleblower
protection laws. Um there's one
additional piece here that I want to
mention because I think it's
particularly relevant in a bioeththics
space. It's duty speech that's raised in
the course of doing one's job. Um it is
protected but it requires something
additional. Um under the WPA that
requires retaliation and what that does
is it shifts the burden onto the
whistleblower to prove a level of
animus. Um, so for all other disclosures
under the whistleblower protection act,
just having a causal link between doing
a protected disclosure and a personnel
action, some sort of retaliation, means
that the whistleblower's rights have
been violated. Um, for duty speech, uh,
the the retaliator, the employer can can
just say there's a business reason for
the decision, and that eliminates the
whistleblowers protections under current
US law.
Um, I'm going to discuss those laws a
little further in detail, excuse me,
later, but I first wanted us to just
look at what whistleblowers look like
uh, recently in this space. So, I've
excuse me,
I've pulled up a number of examples and
I'm not going to go through them all
just in the interest of time. Um, but I
want to show them to folks. You know,
you can see that some whistleblowers in
the past year have exposed information
to Congress about medical contractors,
have um shown over prescription of
hormones to children. Um you'll see uh
private companies here uh that are
committing fraud against the federal
government, right? So that is a key line
that is very common that you'll see in
many of these cases. Um you see leaders
in organizations like Rick Wright and
you also just see individuals who are
working at various facilities um that
come across information of fraud, waste
and abuse and decide to speak up.
Um you know some of these are wellknown
uh the case in the middle there with
Erica Chung um was Therronos was
obviously very widely spoken about in
the media. Um, and then you also have
ones more in the past, you know, with
the painkiller Vio that had very serious
side effects, um, with information being
covered up by the FDA.
I want to give one final example that I
hope folks have already heard about in
their lives, um, at least if you are in
the US. U, but I think folks sometimes
don't think about the role of
whistleblowers um, in them. So the first
is with the Tuskegee syphilis study and
the second is with the Stanford prison
experiment. Um both of those situations
of you know pretty vile um bioethical
violations were first disclosed by
whistleblowers and in one of those cases
worked that whistleblower had to work
really hard to um disclose the
information make it public um ensure
that it was being covered by the media
and they also led to really serious
changes and significant changes in the
way that the US does business um for
example with institutional review
boards.
Um, so I want to just bring us to the
present here and talk about what does
whistleblowing look like in 2026 in this
area. So I gave a number of examples
here and I think it really reflects what
the healthcare bioeththics space needs
and requires. Right? You've got examples
such as, you know, decreasing the role
or disregarding evidence for scientific
advisory committees, censoring
scientific research, limiting the
public's ability to access information.
One of the trend lines here that I often
see and I think folks will identify is
that transparency is incredibly
important on the issue of
whistleblowing. And that's, you know, an
overarching goal and tactic and
rationale and reason why we want
whistleblowers um to have the ability to
speak up.
Uh and that leads us to something that
Taran has already covered in part uh but
I want to bring it to US law. You know,
retaliation is incredibly common for
whistleblowers to experience. And what
does that look like? So under US law,
the office of special counsel, uh this
is not the special counselss that you
might have seen in the news. This is an
office of special counsel. Um
investigates violations of prohibited
personnel practices. Um these are
specific examples essentially of
employment related activities that are
banned uh in the federal workforce.
Retaliation, improper hiring practices,
failure to adhere to laws, rules, and
regulations. And the reason that
Congress put these laws into place is
because it undermines the merit system,
right? It undermines the ability of this
kind of good governance best practice to
function. And a lot of those were
actually already given as examples by
Terran, so I'm not going to repeat them.
Um, I'm going to spend a little time
right now talking about the various
laws, key laws that can protect
whistleblowers in this space. Uh, the
first is the False Claims Act. It's
probably the one that I think is most
widely known um by regular average
Americans um maybe not in its name but
in its function. You know, it's really a
primary tool for fighting fraud um
because it allows individuals to serve
in this role and to sue on kind of on
behalf of the government but to sue in
themselves. Um hospitals, drug companies
for example for defrauding government
programs. Um the way that it works, the
incentive here is that the whistleblower
once uh the government has recouped
those funds, the recovered funds, the
whistleblower receives an award that is
a percentage of that amount. So that can
be quite high. Um there is some
restrictions to it and some process to
it. It can often take many years. Um but
it's a way of ensuring that the US
government can both prosecute fraud and
also get the fraud money back to the
extent possible. Um it's definitely a
key law that Government Accounting
Accountability Project which I work for
uses to protect and defend
whistleblowers. And in these examples,
I've also given some examples of real
life cases um where whistleblowers
stepped forward, used those laws and in
many cases were successful in doing so.
Um another key law is under um
occupational safety. Um it's really
important that workers are able to
report unsafe conditions and know that
they're going to be free from
retaliation if you know they rely on
that job um to have their own
livelihood. um government accountability
project was involved in the expansion of
the law in 2023 and I've given an
example of a community health center
here um which I think is an interesting
one because of the accusations that the
whistleblower faced after they spoke up
you can see this kind of retaliation to
undermine her and the end which was that
a the resolution was that the
whistleblower received a settlement so
we see that quite often um in these
situations as well and that's obvious
That's often a success for
whistleblowers. They get to close the
case. They get restitution for what they
went through. And so we don't see that
as a failure just because it wasn't a
court decision at the end or a jury
decision.
Um, another one is HIPPA that I think
folks in the medical space are
incredibly familiar with. It does have a
set of standards um for whistleblowing
and whistleblowing safe harbor. it's
managed by HHS and I've given an example
on that but I'm not going to go too deep
into it today.
Um similarly the Affordable Care Act
also has a section uh that protects
employees who blow the whistle and we've
seen some examples um of whistleblowing
in that but frankly not very many and
very very rarely do we see it be
successful as a way for whistleblowers
to see protections after they've blown
the whistle. So that's those kind of
things are something to be aware of and
I wanted to make sure to highlight them
today.
And last but certainly not least is
FOYA. Um folks in the US are probably I
hope familiar with FOYA. FOYA is a
transparency law. Um but it's usually
not the first thing that you think of
when it comes to healthcare and
bioeththics. Um because of the patient
patient privacy issues that it comes
with. Um it's a really crucial way that
advocates such advocates such as myself
use um to bring information both for our
advocacy purposes as well as in the
public sphere. Um but it's got some some
serious limitations. Um one the
realities of the health care space. Um
two is that it's limited. There's no
ability to foyer a corporation. You can
foyer a government. Um and there are
some additional limitations on access to
information where the US in particular
has has started to fall behind in
comparison to other countries around the
world. Um and the information asked for
needs to be fairly specific too. So
there's a number of functional issues
with using FI FOYA, but I still think
it's it's pretty key law when we think
about transparency and and sunshine.
Um I'm not going to go too much for the
sake of time here today about current
efforts but I just did want to um offer
it so it'll be available later. Um I
want to talk about utilizing sublower
laws in the US and there's a number of
ways of doing it. you know, non
nonprofit organizations like the one I
work for have published reports and
guides um that can help walk individuals
through what their rights could be and
serve as, you know, kind of like a
research starting point or a steps
situation. There's US federal government
reporting channels like the DOJ one that
I've taken a picture of and put here.
And then there's law firms and attorneys
um many of which actually specialize
specifically in this issue area and they
know those laws as Taran mentioned
anonymity, confidentiality, retaliation
protection. Um those all vary in the US
so it's fairly important for most
whistleblowers to have that advocacy
with them. Um because my work is
legislative and congressional affairs, I
hope folks don't mind. I'm going to take
a minute to really shine a spotlight on
the US Congress. Um, on a practical
level, whistleblowers have a number of
ways to use Congress, come to Congress,
um, involve Congress in their cases.
Many times, of course, not always. The
first, uh, piece of the puzzle here is
Congress's investigative and oversight
powers directly from Article One of the
Constitution. Right? Congress doesn't
just exist to pass laws. Congressional
disclosures are protected under the
Whistleblower Protection Act. um they
require two things, the reasonable
belief of wrongdoing and a disclosure to
an authorized person or entity. So that
obviously doesn't mean just sending a
letter and addressing it to US Congress.
And that doesn't mean also disclosing to
any staff member. Um in many cases there
is going to be an authorized person,
authorized committee um that the
disclosure goes to.
And again, Congress doesn't just pass
laws, reports and studies, letters,
committee hearings, subpoenas. These are
all mechanisms that Congress has in its
toolbox. The most important mechanism
that I think folks sometimes forget is
the bully pulpit. Members of Congress in
their own role as a member, as a leader
of a committee, um, can use their bully
pulpit, their ability to speak out, to
write letters to the editors, to speak
about an issue, to write letters to
companies, uh, to shine a spotlight. And
we've really seen a lot of examples
where whistleblowers suddenly see that
they get the protections that they
deserve under the law um because there's
a additional eyes, right? And then
someone says, "Okay, we've got to do
this correctly or at least more
correctly than they have been."
Uh the last piece that I will highlight
here is the House Office of the
Whistleblower Ombods. It's actually an
office that exists to serve as a
resource for congressional staff when
whistleblowers come to them. Um, so its
mandate doesn't include uh working
directly with whistleblowers. But one
thing that it has done as part of its
work and as part of its mandate is to
put out best practices in a number of
different issue area spaces. One of
which is healthcare whistleblowing. Um,
so I've put the link and a picture here
for folks to see. So, we've been a
really incredible resource the last few
years of having this office and being
able to know and see that congressional
staff, which also have a lot of
turnover, um, are getting additional
training. And so, there's more and more
likely to be someone in a congressional
office who knows what are the best
practices, how do I ensure
confidentiality and anonymity, how do I
work to not screw up this whistleblower
and put them at risk for further
retaliation? Um, so that's really been a
large step forward in how Congress can
work with whistleblowers and make sure
that that information can become public
or at least come to Congress for them to
then be able to use it for their own
investigations and their own oversight
work.
Um, we've talked about Congress. There's
of course also the media, reporters,
public interest organizations,
um of course government agencies with
investigatory or regulatory authority.
And I want to come back to something
that Taran spoke about in one of her
first slides. Um which is what is the
goal of this whistleblower. You know in
individual cases I think we can think
about anonymity and confidentiality and
then some whistleblowers are very
motivated because of financial awards.
So the different reasons for motivation
often play a role in us as whistleblower
advocates thinking about how we want to
support a whistleblower and what makes
the most sense for them and for their
situation moving forward.
Um there's some current threats in this
space. Um in the interest of time I'm
going to skip this one and I'm going to
give an example that I think is a really
interesting one um that we're seeing
right now in the US. Um the FEMA 14 uh
the Federal Emergency Management Agency,
FEMA, has a fairly broad mandate mandate
um on disaster work. Uh about a year
ago, uh it began experiencing mass
layoffs and many programs, many
contracts were cancelled, research was
halted as part of that layoff program.
Um, in August of last year, almost 200
FEMA employees signed a letter and that
was sent to Congress and it identified
issues of gross waste and mismanagement,
abuse of authority, and it was a way for
them to report and to disclose to
Congress, which as I said has this
oversight investigative authority from
our constitution, um, about what was
happening. 30 of those employees uh,
signed their names. The rest were
anonymous.
And what those employees saw was
immediate retaliation within just a
single day. Uh FEMA management placed
those who signed on indefinite
administrative leave. They were
forbidden from entering their offices,
obviously halting their ability to do
their work. And there were retalatory
investigations of those who signed uh
launched really immediately and also of
those who were suspected of signing even
though they were anonymous or they could
be anonymous if they were the ones who
signed. Um so really a full scope of
retaliation very immediately. um
Government Accountability Project filed
a suit on behalf of 14 of those FEMA
whistleblowers um to protect their
whistleblower rights and their first
amendment rights in the US. Um you can
see what the FEMA's own legal council
concluded uh last November the WPA and
the First Amendment rights um were
relevant here and were violated and need
to be protected. Um unfortunately the
employees were reinstated and then
quickly uh that reinstatement was
cancelled in addition retaliation. Um we
also saw some action from Congress. We
had members of congressional committee
speak up about it um right to the office
of special counsel um do a field hearing
uh where they uh had one of the FEMA 14s
speak up and I've included some links to
public reporting on the issue.
Um, so I think that is where my
presentation ends today. More than happy
to answer any questions with Taran and I
hope you all have found this interesting
so far. Thank you so much Maya and
Taran. Those were incredibly insightful
and thoughtprovoking presentations. Um,
please use the Q&A feature if you have
any questions. We've only had two or
three questions so far. I do have plenty
of questions myself, so I'm sure I can
carry us just myself for the next 15
minutes. Um, one theme that seemed to
come through across both talks is that
whistleblowing can be incredibly valued
at identifying individual cases of fraud
and wrongdoing, but possibly less
effective at driving broader structural
change. So, I was curious what's needed
to translate those individual cases into
more meaningful system level reform or
is that not even necessarily the goal of
whistleblowing?
Yeah, I think that uh what we ultimately
want is to detect wrongdoing. So it is
meant to uncover wrongdoing and that
could lead to two things. It could lead
to prosecution or rep repercussions for
the wrongdoer, but it also should lead
to double loop learning. We're not just
interested in the case, but we're
interested in why the case happened and
things that the organization can do to
um prevent that from happening in in the
future. And I do think that uh you know
there was a a case involving um a
medical device manufacturer where they
made their their salespeople were
bribing. And when this came out, they
the company realized that they had put a
lot of pressure on the salespeople to
achieve goals without having adequate
resources. And so they looked at the
systematic drivers of why people were
bribing. Not just punishing the people
who bribed, but in fact they they gave
anonymity to or they gave amnesty to
people who would who would come forward
and talk about the wrongdoing they did.
so that they could make bigger changes
in the organization. So, I think both
are goals.
>> You know, I I think that's interesting,
Taran. Right. And that's a really great
example of a company that that sees it
in their interest to make those changes.
Um, another thing that the organization
I work for, Government Accountability
Project, has seen is that some cases of
whistleblower, some some examples of
whistleblowing
can be really good drivers uh to new
policy, whether that's regulatory or
through Congress. Um, many times I found
that members of Congress, their offices,
their staff want examples. They want the
real life, you know, why does this thing
matter? And also having that example if
it's having a whistleblower who is
willing to talk to the staff members to
say this is what I experienced or even
having a collection of whistleblowers
and having an organization that says you
know here is what we have seen over the
decades with thousands of whistleblowers
can serve as a motivator for you know
those oversight hearings for legislation
for incorporating the lessons learned
from whistleblowers into new law. uh
many of the US laws are built off the
backs of whistleblowers who stepped
forward, who experienced retaliation,
who found the gaps and once those gaps
were identified, when there's, you know,
movement in Congress that can become law
and future whistleblowers don't have to
go through the same thing or have
additional protection. Um so when they
step forward, they're not risking their
livelihoods as much and their lives um
in the same way as they did in the past.
Um that is a is a massive goal I think
at at least in the US and I think around
the world that most people can agree is
a positive. We want to be able to learn
um from instances of whistleblowing. We
want to be able to you know learn from
instances of you know bioeththics
violations like some of the examples I
showed before. Um and create a better a
better space better norms. Um and those
norms have to be driven or
can be very much helped by being driven
um by laws that that actually protect
folks and require certain things. Um so
I think that's that's an important piece
of the puzzle as well. Um many
organizations um government
accountability included engage in what
we think of as impact litigation. So,
our practicing attorneys will take cases
that we see as having really widespread
implications that say something about
policy um and kind of build that into a
a broader campaign of why things should
change, why protection should be had,
etc.
>> Thank you. And then switching gears a
bit, there were a couple questions about
the politicization of whistleblowing and
the use of the false claims act in a
more politically contested areas like
DEI or gender affirming care. Does that
change how we should think about
whistleblowing? And more broadly, how
should we think about the weaponization
of whistleblowing, including its use
against marginalized groups?
>> You know, uh, whistleblowing in the US,
uh, was something that came up during
the founding father's time. It's been
around for a long time. Um, there was a
instance of whistleblowing, I think, in
in the Confederate army. Um, so
whistleblowing has long been a
bipartisan goal, crosspartisan,
nonpartisan, whatever you want to call
it. Um, we have seen, you know, in the
last years, um, more polarization in how
folks think about a whistleblower, um,
whether that whistleblower happens to to
talk about an issue that that is
important to them, um, or aligns with
their goals. for us as an organization
um whistleblowers deserve protections
and they deserve identification as a
whistleblower
um across the board and that's really
important. I think instances where
whistleblowers are undermined um is very
hard to see and the implication of that
of course is you know a potential
um minimization or or retrenchment of
whistleblower protection laws which is
really deeply concerning. Um so making
sure that whistleblower champions on
Capitol Hill um whistleblower advocates
in Washington DC, across the US,
internationally as well of course um are
continuing to uplift whistleblowers and
acknowledge what they've put on the line
in order to speak truth um is really
important.
>> Um and then there was a question related
to incentives uh and whistleblowing. So
it seems with the false claims act uh
the US has placed certain some strong
financial incentives on whistleblowing.
Um how well do these incentives work and
there are there gaps when the harm is
primarily to patients scientific
integrity or public health rather than
government spending and how should we
think about you know incentives more
broadly when it comes to whistleblowing.
Taran, I'm wondering if you want to
speak to your research that that found
how incentives can push people to come
forward or you want me to take it?
>> I think um if you could take it, it'd be
good. I'm I'm not sure I I'm Are we
looking for more than a financial award
or
I'm not quite sure I understood the
question. So, so it seems like a lot of
well the false claims act was about
recovery for the government but there
are a lot of different avenues for which
whistleblowers uh reveal very important
information related to like patient
safety and you know a lot of different
areas where there it's not necessarily
tied to recovery of money. So are there
ways we could more incentivize those
forms of whistleblowing? Yeah,
definitely. And I I think what the
literature has showed is that leadership
in the organization is very important
and leadership in the profession. So um
we s we saw in the multilateral
organizations and in nursing that there
are powerful professional um
professionalization norms that say you
see something that's wrong. It's it's
really important that you talk about it
and a leader can make this clear as well
and being able to talk about these
things and not shy away from it because
we want to pretend. I mean, the US makes
a return on investment of five to eight
dollars per $1 spent in fraud
investigations and fraud trying to
detect and uh recover from fraud. So,
they make money on it more more than
they're spending, but US doesn't want to
invest in it because they're ashamed
that they have fraud because if you
investigate fraud and you find it,
that's a bad thing. And I think it
that's where leaders don't want to talk
about it. They don't want to acknowledge
it because they don't want to have a
reputational hit by having corruption.
But but I do think we do things because
leaders make it possible for us to do
things. So I think this is a way where
people could, you know, make it clear
that there's a mechanism, let everybody
know about the mechanism. I mean, my
students tried a whistleblowing portal
in one organization and found that it
wasn't working and they were able to
they just dialed the number just to see
what it would be like to, you know, what
was going to happen when they called and
it was out of order. Nobody knew that on
the staff, you know. So, they you want
to make sure these systems really work
and, you know, talk to people. If there
aren't lots of reports, then maybe this
system isn't working or there's no
reporting at all happening, you know,
let's find out what's going on.
>> Yeah, I I think that's something I've
seen as well. Um this idea of well,
there's not that many reports, so
everything must be, you know, flowing
swimmingly. Um and that's not
necessarily the case, right? It could
mean that whistleblowers don't feel that
they can step forward and say, "Hey, I'm
seeing something." Um maybe concerns
raised to supervisors are being shut
down. You know, retaliation protections
are incredibly important because I think
most people will think to themselves,
well, I see this information. I came
across it. It's not good. I don't know
what to do. Someone's lives are at risk.
You know, safety is at risk. Um and they
also have, you know, in most cases, um
you know, well, I need to have my job. I
need to have my livelihood. what will
happen if I'm blacklisted from my
industry um after I do this, after I
step forward and say something about it.
Um so that cultural context is
incredibly important and raising a
culture where whistleblowers are
respected and honored is really
important. Um every year July 30th,
whistleblower advocacy organizations and
whistleblowers celebrate National
Whistleblower Day. It's not a federal
holiday in the US, but we still
celebrate it. And one of the things that
we've heard from whistleblowers is just
being in a room where I'm being
respected and I'm being honored. I'm
being said told, you know, this is a
really good thing what you did. It was
brave. It was helpful. Um, it saved
lives. It made our community better. Um,
it's really important to them. And it's
also, I think, turn it sounds like also
really important for future
whistleblowers to know, well, this is
how whistleblowers are treated. Um, so
if I come across fraud, waste, and
abuse, I can step forward and be treated
like that and not terribly.
>> Great. Bringing off that, you have both
discussed how country context and
culture shape whistleblowing. Are there
examples where shifts whether it's in
norms, protections or institutions uh
have that have made whistleblowing more
effective? Um, and what drove uh drove
those changes?
Well, and it doesn't even have to be
countrywide. It could be within, you
know, organizations.
>> Well, I I can think of I uh it was very
helpful for the global fund. They
publicized when they had an incident of
corruption and they I mean it really was
a small amount compared to how the
billions that they give. It was a small
amount that was affected but they they
followed through and they made sure that
um there were repercussions for the
country and uh for the people who had
engaged in the fraud and after that they
created various portals and one was
through the global fund itself but also
for through watchdog organizations if
people don't feel comfortable go
complaining to the independent um
inspector general in an organization,
they can go to this NGO that will then
feed those complaints to the
organization. Um but they they did have
success because they were transparent in
publishing reports. They have the best
reports of their fraud investigations,
you know, lots of good detail. They're
putting it out there and then they're
following up and having rep, you know,
having um repercussions for for the act
of the fraud, not just letting it go
because, oh, we got to work with these
people, so let's just sweep it under the
rug. And I think that made a difference
also having the resources for people and
repeating the education. I think it's
it's it's not one and done. You don't
just tell people uh even having an
ombbudz in an organization or an
integrity line that's not whistleblowing
but you just have a you have a dilemma
and you want to talk to someone about
it. I mean having these kind of
resources for people who may or may not
end up blowing the whistle but who want
to explore something that's really
important to give them help.
>> Great. I think we have time for one more
question. Um it's uh my you mentioned
the federal court case which represents
a major potentially existential threat
to whistleblowing at least the false
claims act under the false claims act.
Um and it it seems like whistleblowing
has traditionally been seen as a
bipartisan tool for uh exposing fraud
and and misconduct and really protecting
public resources. Do you think the polit
the politics around whistleblowing are
shifting and how do we ensure the uh
future longevity and sustainability of
whistleblowing?
>> Yeah. Um you know I appreciate the
question. I think that whistleblowing
remains a really strongly championed
issue by people across different
political persuasions with different
viewpoints on other things. I know that
when we do whistleblower advocacy in DC,
in the US, um we have an international
program as well at our organization. I
know how many different people we work
with, how many different types of
organizations, and we really see
championship of whistleblower protection
laws from very high up members of
Congress and senators um across the
board. So I am really optimistic that
whistleblower has been remains um a
really powerful tool that has
acknowledgment of that and that uh
whistleblowers continue to be honored
and respected. Uh that takes continued
education, right? As Taran just said,
you know, staff at various organizations
need continuing training and education
and so does the public. So do advocates.
Um so that goes across the board. Um,
and I actually see a future where
whistleblowing continues to be really
highly respected, acknowledged for being
incredibly important. Um, and that
framework is is one tool, but a really
important tool um, for how we want how
we want to fight fraud.
>> I think that's a great positive note to
end on. Leah, do you want to take it
from here?
>> Yes. Thank you. And thank you to for you
to you for this wonderful conversation.
And I want to thank the hosts of this
webinar uh the Petri Flom Center the
center for bioeththics and the program
on regulation therapeutics and law and
my co-convener Erin Kessleheim. And so
thank you uh Dr. Van Ephi man for for
leading us through this discussion today
and providing resources like what what
it is that we can do as individuals. Um
and thank you to everyone who joined us
this afternoon and we will see you next
year.